Skip to main content

Mountain Crest Acquisition Corp. V

corporate_fare Company Profile

Mountain Crest Acquisition Corp. V

MCAGR·OTC·Industrial Applications And Services·CIK 0001859035

Mountain Crest Acquisition Corp. V is a blank check company incorporated in Delaware on April 8, 2021. The company was formed to complete a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, referred to as its initial business combination. While there are no restrictions on the industry or geographic region of a target business, Mountain Crest Acquisition Corp. V intends to pursue prospective targets in North America and the Asia Pacific regions, specifically excluding China, Hong Kong, and Macau. The company will not undertake its initial business combination with a target business that has its principal business operations in China, including Hong Kong and Macau. On October 19, 2022, the company entered into a Business Combination Agreement with AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singapore with company registration 201810204D. This agreement was subsequently amended on February 10, 2023, March 30, 2023, and April 19, 2023. On January 27, 2023, AUM Biosciences Limited, a Cayman Islands exempted company, AUM Biosciences Subsidiary Pte. Ltd., a private company limited by shares incorporated in Singapore with company registration number 202238778Z and a direct, wholly-owned subsidiary of Holdco, and AUM Biosciences Delaware Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Holdco, joined the Business Combination Agreement as parties. The Business Combination Agreement would have provided for the initial business combination of the company, subject to its terms and conditions.

Mountain Crest Acquisition Corp. V (OTC:MCAGR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 1 item for MCAGR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-01, rated 7/10. Recent SEC coverage for MCAGR spans PRE 14A.

Recent high-impact activity:

  • SPAC Seeks Sixth Extension to May 2027 as CubeBio Deal Nears Vote

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$431.16K
Op. Cash Flow
-$742K
Operating Income
-$471.78K
Cash & Equivalents
$11.91K
Debt / Equity
0.00×
Shares Outstanding
2.8M sh
Source: 10-K · filed 2026-03-13 · accession 0001829126-26-002303

Short Interest & Short Volume

FINRA reported short interest of 29 shares in MCAGR as of the September 15, 2026 settlement, unchanged from the prior period.

Short interest (bi-monthly positions)29 shares as of September 15, 2026
Change vs prior period 0.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$0.03
52-week range · as of 2026-10-01 $0.0003 – $0.3815
Market cap
$38.13M
Volume
2.5K (0.2× avg)
3-mo avg 11.6K
From SEC filing · 2026-10-01

show_chartPrice Chart

Loading chart...

feed MCAGR - Latest Insights

MCAGR
Oct 01, 2026, 8:30 AM EDT
Filing Type: PRE 14A
Importance Score:
7
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets